Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation by Stanley, Christopher et al.
  Page 1 of 1 
FedUni ResearchOnline 
https://researchonline.federation.edu.au 
Copyright Notice 
 
This is the author’s preprint version of the following publication: 
Stanley, C. P., et al. (2019). "Singlet molecular oxygen regulates vascular tone and blood 
pressure in inflammation." Nature 566(7745): 548-+. 
 
The version displayed here may differ from the final published version. 
The final publication is available at Springer via: 
https://doi.org/10.1038/s41586-019-0947-3 
Copyright © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. 
CRICOS 00103D RTO 4909   
	 1 
Singlet molecular oxygen regulates vascular tone and blood pressure in 
inflammation 
Authors: Christopher P. Stanley1†, Ghassan J. Maghzal1,2†, Anita Ayer1,2, Jihan Talib1,2, Andrew 
M. Giltrap3, Sudhir Shengule1, Kathryn Wohlhuter1, Yutang Wang4¶, Preet Chadha1, Cacang 
Suarna1, Oleksandra Prysyazhna5, Jenna Scotcher5, Louise L. Dunn1,2, Fernanda M. Prado6, Nghi 
Nguyen7, Jephthah O. Odiba7, Jonathan B. Baell7,8, Johannes-Peter Stasch9, Yorihiro Yamamoto10, 
Paolo Di Mascio6, Philip Eaton5, Richard J. Payne3 and Roland Stocker1,2* 
1Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia 
2St Vincent’s Clinical School, University of New South Wales, NSW 2052, Sydney, Australia 
3School of Chemistry, The University of Sydney, Sydney, NSW 2006 Australia 
4Centre for Vascular Research, School of Medical Sciences (Pathology), and Bosch Institute, 
Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia 
5Department of Cardiology, Cardiovascular Division, King’s College London, and The Rayne 
Institute, St. Thomas’ Hospital, London SE1 7EH, UK 
6Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil 
7Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 
Victoria 3052, Australia 
8School of Pharmaceutical Sciences, Nanjing Tech University, No. 30 South Puzhu Road, Nanjing 
211816, People’s Republic of China 
9Cardiovascular Research, Bayer AG, Wuppertal, Germany 
10School of Bioscience and Biotechnology, Tokyo University of Technology, Tokyo, Japan 
†These authors contributed equally to this manuscript 
¶Present address: School of Health and Life Sciences, Federation University Australia, Ballarat, 
VIC 3350, Australia 
*Correspondence to: r.stocker@victorchang.edu.au 
  
	 2 
Singlet molecular oxygen (1O2) has well-established roles in photosynthetic plants, bacteria 
and fungi1-3, but not in mammals. Chemically generated 1O2 oxidizes the amino acid 
tryptophan to precursors of a key metabolite called N-formylkynurenine4, while enzymatic 
oxidation of tryptophan to N-formylkynurenine is catalyzed by a family of dioxygenases, 
including indoleamine 2,3-dioxygenase 15. Under inflammatory conditions, this heme-
containing enzyme becomes expressed in arterial endothelial cells, where it contributes to the 
regulation of blood pressure6. However, whether indoleamine 2,3-dioxygenase 1 forms 1O2 
and whether this contributes to blood pressure control is unknown. Here we show that 
arterial indoleamine 2,3-dioxygenase 1 regulates blood pressure via formation of 1O2. We 
observed that in the presence of hydrogen peroxide, the enzyme generates 1O2 and that this is 
associated with the stereoselective oxidation of L-tryptophan to a tricyclic hydroperoxide via a 
previously unrecognized oxidative activation of the dioxygenase activity. The tryptophan-
derived hydroperoxide acts as a hitherto undiscovered signaling molecule in vivo, which 
induces arterial relaxation and decreases blood pressure dependent on cysteine residue 42 of 
protein kinase G1α . Our findings demonstrate a pathophysiological role for 1O2 in mammals 
through formation of an amino acid-derived hydroperoxide that regulates vascular tone and 
blood pressure under inflammatory conditions. 
Several small molecules, such as nitric oxide and hydrogen peroxide (H2O2) regulate cellular 
signaling via interaction with proteins containing redox active metals and/or cysteine residues. Of 
these molecules, nitric oxide, formed from L-arginine by endothelial nitric oxide synthase, is an 
important regulator of vascular tone7. Sustained increases in nitric oxide synthesis by inducible 
nitric oxide synthase, as observed in pathological settings such as sepsis, are associated with 
profound hypotension8. Paradoxically, inhibitors of the nitric oxide pathway have generally failed 
to ameliorate severe septic shock9,10, suggesting involvement of additional mediators of 
hypotension. 
Based on functional similarity with the metabolism of L-arginine by nitric oxide synthase, we 
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reported previously that metabolism of L-tryptophan (Trp) to N-formylkynurenine (NFK) and 
kynurenine by endothelial indoleamine 2,3-dioxygenase 1 (IDO1) (Fig. 1a) contributes to the 
regulation of vascular tone and blood pressure in inflammation6. We also showed that commercial 
kynurenine relaxed pre-constricted arteries, which suggested that kynurenine is an endothelium-
derived relaxant factor6. Although others have since confirmed these findings11,12, we noticed that 
recently purchased kynurenine no longer caused arterial relaxation, and that HPLC-purified 
kynurenine and NFK also failed to relax naïve mouse arteries (Fig. 1b). However, purified Trp 
relaxed pre-constricted mouse abdominal aortas that expressed IDO1, irrespective of whether IDO1 
expression was induced in vitro by treating arteries with interferon-γ or in vivo by treating mice 
with lipopolysaccharide6 (Fig. 1c, d). These findings indicated that the ‘relaxing factor’ derived 
from Trp is likely a biosynthetic metabolite ‘upstream’ of NFK and that earlier commercial 
preparations of kynurenine might have contained this molecule as a contaminant. 
As chemical oxidation of Trp by 1O2 yields products that decay to NFK4, and commercial 
kynurenine can be produced via Trp oxidation by 1O213, we exposed Trp to 1O2 in vitro. Such ‘1O2-
exposed Trp’ dose-dependently relaxed endothelium-denuded naïve abdominal aortas that do not 
express IDO1 (Fig. 1e). HPLC/UV analysis revealed ‘1O2-exposed Trp’ to contain eight distinct 
compounds (labeled Peaks 1-8, Fig. 1f). By comparison to authentic standards, Peaks 7 and 8 were 
identified as NFK and Trp, respectively. Of the remaining six individually purified peaks, only Peak 
6 was able to substantially relax naïve arteries in a dose-dependent manner (Fig. 1g, Extended data, 
fig. 1a). Purified Peak 6 also dose-dependently relaxed conduit and resistance arteries from mouse, 
rat and pig (Extended data, fig. 1b-f), indicating that 1O2-mediated oxidation of Trp generates a 
compound that relaxes arteries in a vascular bed- and species-independent manner. 
We next focused on the chemical identification of the compound eluting in Peak 6. Liquid 
chromatography mass spectrometry (LC-MS) analysis of ‘1O2-exposed Trp’ showed that the 
compounds eluting in Peaks 5 and 6 had a molecular weight of 237 (single ions with m/z 237), and 
the compounds that eluted in Peaks 2 and 4 had a molecular weight of 221 (Extended data, fig. 2a). 
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This suggests the incorporation of two and one oxygen atom(s) into Trp (m/z 205), respectively. 
The MS/MS fragmentation spectra (Extended data, fig. 2b) indicated the compounds of Peaks 2 and 
4, and Peaks 5 and 6 to be isomers of each other. Subsequent analysis by 1H and 13C nuclear 
magnetic resonance (NMR) suggested that the molecules that eluted in Peaks 5 and 6 in the HPLC 
are tricyclic Trp-derived hydroperoxides with O2 incorporated at carbon 3a4, whereas the molecules 
that eluted in Peaks 2 and 4 are the corresponding tricyclic hydroxides (trans- and cis-WOH, 
respectively) with a single oxygen atom incorporated at carbon 3a (Extended data, table 1). We 
confirmed Peaks 5 and 6 as hydroperoxides by HPLC with post-column chemiluminescence 
detection14 (Extended data, fig. 3a). Chemical reduction of purified Peaks 5 and 6 eliminated their 
chemiluminescence response (Extended data, fig. 3b) and resulted in retention times, molecular ions 
and fragmentation patterns, and 1H NMR spectra identical to those of Peaks 2 and 4, respectively 
(Extended data, figs. 3c-d). This data confirmed that Peaks 2 and 4 are the hydroxides of the 
corresponding hydroperoxides, Peaks 5 and 6, respectively. 
To unequivocally assign the stereochemistry of the molecules that eluted in Peaks 5 and 6, we 
performed Nuclear Overhauser Effect (NOE)-difference NMR on the corresponding stable 
hydroxide derivatives, Peaks 2 and 4. Irradiation of the resonance at ~5.2 ppm, corresponding to 
proton H8a in the 1H NMR of purified Peaks 2 and 4, resulted in a clear NOE signal with the α-
hydrogen (H2) in the case of Peak 2 but not Peak 4 (Extended data, figs. 4a-d). Observation of a 
NOE signal is indicative of protons H8a and H2 being on the same face of the molecule, which 
provides information about the relative stereochemistry and suggests that Peak 2 corresponds to the 
trans-configured tricyclic hydroxide. From these findings, extensive 2D NMR analyses, and 
comparison of the NMR data with relevant literature4,15, we concluded that the molecule eluting in 
Peak 6 is the tricyclic Trp-derived cis-hydroperoxide ((2S,3aR,8aR)-3a-hydroperoxy-1,2,3,3a,8,8a-
hexahydropyrrolo[2,3-b]indole-2-carboxylic acid) (Fig. 1h), hereafter referred to as cis-WOOH, 
while the molecule that eluted in Peak 5 is the corresponding 3a, 8a-epimer trans-WOOH (Fig. 1a), 
in which both positions 3a and 8a are inverted with respect to cis-WOOH. Incubation of cis-WOOH 
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at 37 °C and pH 7.4 led to its stoichiometric conversion to NFK, as examined by 
spectrophotometry, NMR and LC-MS/MS (Extended data, figs. 5a-c), thus establishing cis-WOOH 
as a precursor of NFK. Thermal decomposition of cis-WOOH also led to emission of light with 
maxima at 489 nm, characteristic of activated carbonyls16 (Extended data, fig. 5d). Based on these 
findings and known chemistry4, a plausible scheme for 1O2-mediated conversion of Trp to cis-
WOOH and its decay to NFK can be proposed (Extended data, fig. 5e). 
IDO1 is known as a reductively activated dioxygenase, requiring reduction of its Fe3+-heme 
prosthetic group to Fe2+-heme for activity17. To investigate the potential conversion of Trp to cis-
WOOH by recombinant human IDO1, we first used superoxide radical anion (O2•–) as a reductant18 
in the presence of Trp and catalase. This resulted in the formation of NFK (Fig. 2a, top) and small 
amounts of cis-WOH, but not cis-WOOH. The observed formation of cis-WOH supports the 
previously reported conversion of Trp to a tricyclic hydroxide by reductively activated IDO119. 
Using cytochrome b5/cytochrome P450 reductase as a reducing system20 also yielded NFK and cis-
WOH but not cis-WOOH (Fig. 2a, middle), demonstrating that cis-WOOH is not a product of 
reductively activated dioxygenase activity of IDO1. Because inflammation is associated with 
increased H2O2 and IDO1 also possesses peroxidase activity21, we next examined Trp oxidation by 
IDO1 in the presence of H2O2. Under these conditions, cis-WOOH was formed as the major 
product, in addition to NFK, the known peroxidase product oxyindolylalanine22, and trace amounts 
of trans-WOOH (Fig. 2a bottom, Fig. 2b). In contrast, oxidation of Trp with chemically generated 
1O2 yielded more comparable amounts of cis- and trans-WOOH (Fig. 1f, Extended data, figs. 6a-b), 
indicating that IDO1/H2O2 formed cis-WOOH as an enzymatic reaction product. Consecutive 
addition of H2O2 at sub-stoichiometric amounts to IDO1 resulted in an H2O2 concentration-
dependent increase in cis-WOOH, with ~0.3 mol of cis-WOOH formed per mol of H2O2 (Fig. 2b). 
Pharmacological inhibitors of IDO1 decreased IDO1/H2O2-mediated formation of cis-WOOH, with 
the L-isomer of 1-methyltryptophan (1-MT) being more effective than the D-isomer, and with 
epacadostat and NLG919 (i.e., IDO1 inhibitors of interests as potential anti-cancer adjunct 
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therapies23) being more effective than 1-MT (Extended data, fig. 6c). 
Further mechanistic studies revealed that cis-WOOH is the product of a previously 
unrecognized oxidatively activated dioxygenase activity of IDO1 (Fig. 2c). Thus, replacing 16O2 
with 18O2 increased the m/z of cis-WOOH by 4 amu to 241. In contrast, in reactions using 16O2 and 
H218O2 instead of H216O2, cis-WOOH retained an m/z of 237 (Fig. 2c, bottom), demonstrating that 
the two oxygen atoms inserted into Trp to form cis-WOOH are derived from O2 rather than H2O2. 
The O2-dependence of the Trp to cis-WOOH conversion was confirmed by a small but significant 
increase in cis-WOOH when the reaction mixture was saturated with O2, whereas displacing O2 in 
the reaction mixture with argon decreased cis-WOOH (and NFK) but not oxyindolylalanine (Fig. 
2d). 
To determine whether cis-WOOH is formed in vivo, we pretreated porcine coronary arteries 
with interferon-γ to increase IDO1 expression6 and to mimic inflammatory conditions. Such 
treatment increased arterial H2O2 (Fig. 2e) and led to the production of cis-WOOH (Fig. 2f), the 
latter detected by the arterial conversion of 15N2 Trp to 15N2 cis-WOOH. Furthermore, addition of 
catalase conjugated to polyethylene glycol to scavenge arterial H2O2 (but not polyethylene glycol 
alone) significantly attenuated Trp-induced relaxation of interferon-γ-pretreated mouse arteries (Fig. 
2g). Together, these data suggest that under inflammatory conditions arteries produce cis-WOOH 
from Trp and that this is involved in Trp-induced arterial relaxation mediated by IDO1 and H2O2. 
We next investigated whether IDO1 in the presence of H2O2 generates 1O2. Addition of H2O2 to 
Singlet Oxygen Sensor Green (SOSG) and IDO1 resulted in an immediate increase in fluorescence 
that is characteristic of the 1O2-specific SOSG endoperoxide that was absent when IDO1 was 
replaced with albumin (Fig. 3a). Similarly, IDO1/H2O2 converted anthracene-9,10-diyldiethane-2,1-
diyl disulfate disodium salt (EAS)16 to its 1O2-specific endoperoxide, EAS-O2 (Fig. 3b). 
Unambiguous evidence for the formation of 1O2 by IDO1/H2O2 was obtained using near infrared 
emission at 1270 nm, which corresponds to the singlet delta state monomolecular light emission 
decay of 1O224. Addition of active, but not heat-inactivated IDO1, to H2O2 concentration-
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dependently increased 1270 nm emission (Fig. 3c). Performing the reaction in H2O rather than D2O, 
as well as removing oxygen, prevented 1O2 formation. Similarly, carbon monoxide prevented 1O2 
generation (Fig. 3c, Extended data, fig. 6d and e), indicating the requirement of the heme iron of 
IDO1 for formation of 1O2. By comparison, nitric oxide partially inhibited 1O2 formation (Fig. 3c, 
Extended data, fig. 6d), consistent with its previously reported reversible inhibition of IDO1 
activity25. Together, these findings show, for the first time, that reaction of IDO1 with H2O2 
generates 1O2. 
To assess whether IDO1/H2O2-derived 1O2 was utilized for cis-WOOH formation, we 
performed the reaction in D2O to extend the half-life of 1O224. This increased the yield of cis-
WOOH relative to that of oxyindolylalanine (Fig. 3d), while the structurally diverse 1O2 scavengers 
L-histidine, SOSG, cis-norbixin and urate decreased the cis-WOOH yield (Fig. 3e). LC/MS-based 
quantification of IDO1/H2O2-mediated conversion of EAS to EAS endoperoxide revealed 
comparable amounts of 1O2 and cis-WOOH were formed (Fig. 3f), indicating that the 1O2 generated 
by IDO1/H2O2 accounted for most cis-WOOH formed. Similarly, the amounts of cis-WOOH 
formed by IDO1/H2O2 were comparable to the extent of conversion of urate to its 1O2-specific 
oxidation product, parabanic acid26 (Fig. 3g). This is consistent with the near complete prevention 
of cis-WOOH (Fig. 3e) and SOSG fluorescence (Extended data, fig. 6d) by urate and indicates that 
the end product of purine metabolism in humans efficiently scavenged the 1O2 formed by 
IDO1/H2O2. Together, these results suggest that IDO1/H2O2 generate cis-WOOH from Trp via 1O2, 
and that 1O2 is formed in or near the active site of the enzyme rather than being released into the 
bulk phase. This conclusion is supported by the observation that the presence of Trp blocked the 
ability of SOSG to react with 1O2 (Fig. 3a) and decreased 1270 nm emission (Fig. 3c). 
If 1O2 were required for conversion of Trp to cis-WOOH, other enzymes known to form 1O2 in 
the presence of H2O227 may also be able to convert Trp to cis-WOOH. Indeed, horseradish 
peroxidase and myeloperoxidase, as well as purified IDO2, formed cis-WOOH, albeit with lower 
stereospecificity than IDO1 (Extended data, fig. 6f). The fact that IDO2, like IDO1, generated cis-
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WOOH in the presence of H2O2 raised the possibility that IDO2 may also contribute to Trp-
mediated arterial relaxation under inflammatory conditions. To test this possibility, we compared 
Trp-induced relaxation of IFNγ-pretreated abdominal aortas of WT, Ido1–/– and Ido1–/–Ido2–/– mice. 
Relaxation was attenuated to a comparable extent in arteries from Ido1–/– and Ido1–/–Ido2–/– mice 
(Extended data, fig. 6g). This indicates that under the conditions tested IDO2 may not play a 
significant role in arterial relaxation, consistent with a lack of evidence for arterial expression of 
IDO2 in naïve animals or under conditions of inflammation. 
Known mechanisms of 1O2 generation by dark reactions in biochemical systems involve 
superoxide radical anion, thiyl radicals, hypochlorite plus H2O2, energy transfer from excited triplet 
carbonyls, or peroxyl radicals.27 In the case of IDO1/H2O2, superoxide and thiyl radicals are likely 
not involved since addition of superoxide dismutase (to scavenge superoxide) or N-ethylmaleimide 
(to block thiols) did not affect cis-WOOH formation (Extended data, fig. 7a and b). Any 
involvement of hypochlorite was excluded based on the absence of conversion of hydroethidine to 
2-chloroethidium28 by IDO1/H2O2 (Extended data, fig. 7c). In addition, sorbate, a scavenger of 
excited carbonyls16, decreased the yield of cis-WOOH formation modestly, whereas the oxygen-
centered radical scavenger, 5,5-dimethyl-1-pyrroline N-oxide (DMPO) was more effective 
(Extended data, fig. 7d). The implied involvement of protein peroxyl radicals in the formation of 
1O2 by IDO1 was supported by the appearance of IDO1 dimers (upper arrow in Extended data, fig. 
7e), IDO1-associated dityrosine-specific fluorescence (Extended data, fig. 7f), and protein 
hydroperoxides (Extended data, fig. 7g). DMPO effectively inhibited the formation of these species, 
just as it inhibited IDO1/H2O2-mediated conversion of EAS to EAS-O2 (Extended data, fig. 7h). 
These findings and previous studies by others29 suggest that the reaction of IDO1 with H2O2 yields 
a porphyrin radical, which delocalizes to aromatic amino acid residues of IDO1, most likely a Tyr 
residue. The resulting amino acid-derived phenoxyl radical may then engage in dityrosine 
formation, β-scission and/or fragmentation reactions, as well as formation of protein peroxyl 
radicals (Extended data, scheme 1), in accordance with known chemistry30. Consistent with this 
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possibility, reaction of IDO1 with H2O2 generated IDO1 fragments (double arrow in Extended data, 
fig. 7e) and excited carbonyls (Extended data, fig. 7i), both of which were inhibited by Trp and 
DMPO. Moreover, others reported previously22 that in the presence H2O2 and DMPO, IDO1 
generates IDO1-DMPO adducts, indicative of protein radicals31. Based on these results, we propose 
the Russell mechanism32 as a possible pathway for the formation of 1O2 by IDO1/H2O2 (Extended 
data, scheme 1). 
Having established the importance of 1O2 in IDO1/H2O2-mediated formation of cis-WOOH, we 
examined the effect of 1O2 scavenging on Trp-induced IDO1-mediated arterial relaxation. Addition 
of the 1O2 scavengers L-histidine, urate or cis-norbixin to interferon-γ-pretreated arteries from 
wildtype mice significantly attenuated relaxation mediated by Trp but not nitric oxide (Fig. 3h-i, 
Extended data, fig. 6h), an effect not seen with arteries from Ido1–/– mice (Fig. 3h). Moreover, 
addition of urate to interferon-γ-pretreated arteries resulted in the accumulation of parabanic acid 
(Fig. 3j). Together, these data indicate that IDO1-expressing arteries form 1O2 under conditions that 
mimic inflammation. 
Having identified cis-WOOH as a novel relaxant derived from Trp via IDO1-mediated 
formation of 1O2, we next focused on the mechanism of cis-WOOH-mediated relaxation in 
resistance arteries. Given the role of protein kinase G (PKG) in arterial relaxation, we focused on 
this as the initial target of cis-WOOH. The cGMP-competitive PKG inhibitor RP-8CPT modestly 
attenuated cis-WOOH-mediated relaxation, whereas the ATP-competitive PKG inhibitor KT5823 
was more effective (Extended data, fig. 8a, b), suggesting cGMP-independent activation of PKG by 
cis-WOOH. PKG1α is known to undergo H2O2-mediated oxidative dimerization through cysteine 
residue 42 (C42), which targets the kinase and is associated with its activation33. Amino acid 
hydroperoxides can also oxidize protein thiol residues34. Interestingly, we observed that cis-
WOOH, but not trans-WOOH, dimerized purified recombinant human PKG1α (Fig. 4a). cis-
WOOH-mediated dimerization was independent of the presence of transition metals and light, but 
dependent on C42 of PKG1α, as the C42S mutant of PKG1α was refractory to dimerization (Fig. 
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4a). Exposure of resistance arteries of wildtype (Fig. 4b, left) and Ido1–/– mice (Fig. 4b, right) to cis-
WOOH also caused PKG1α dimerization, as was observed with Trp addition to IDO1-expressing 
arteries (Fig. 4c). Compared with the wildtype counterparts, mesenteric arteries from PKG1α C42S 
knock-in mice35 showed blunted relaxation in response to cis-WOOH and Trp, but not the nitric 
oxide donor DEANO (Fig. 4d). 
We previously reported that Ido1–/– mice are partially protected from hypotension induced by 
experimental cerebral malaria and endotoxemia6, and that IDO1 activity increases considerably and 
predicts the vasopressor needs in patients with severe sepsis36. To examine the role of the IDO1/cis-
WOOH/PKG1α in the regulation of blood pressure in inflammation, we therefore compared 
systolic blood pressure responses in unconscious endotoxemic wildtype and PKG1α C42S knock-in 
mice. Infusion of Trp decreased blood pressure temporarily in wildtype but not knock-in mice (Fig. 
4e), while IDO activity was comparable between the two genotypes (Extended data, fig. 8d and e). 
In contrast to Trp, the hypotensive response to sodium nitroprusside, that activates PKG1α via the 
canonical non-oxidative pathway, was comparable in wildtype and PKG1α C42S knock-in mice 
(Fig. 4f). These data directly support the notion that the Trp-induced decrease in blood pressure of 
endotoxemic mice is mediated via non-canonical oxidative activation of PKG1α involving C42. 
As H2O2 itself can induce arterial relaxation via C42-dependent oxidative dimerization of 
PKG1α, we asked whether this pathway overlaps with PKG1α oxidation by cis-WOOH. To 
examine this possibility, we tested the effect of Trp on acetylcholine-induced relaxation of resistant 
mesenteric arteries that is considered to be mediated by H2O2.37 Trp and 1-MT had no material 
effect on arteries isolated from naïve mice (Fig. 4g), whereas Trp sensitized and 1-MT attenuated 
the relaxation of arteries from endotoxemic mice (Fig. 4h). Moreover, addition of Trp to IDO1-
expressing human vascular smooth muscle cells augmented PKG1α dimerization by 1 µM H2O2, a 
concentration that itself did not induce measurable dimerization (Fig. 4i). These results suggest that 
under inflammatory conditions, H2O2-induced regulation of arterial relaxation via PKG1α oxidation 
may be partially mediated by IDO1/cis-WOOH. 
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We finally tested the potential role of IDO1/cis-WOOH in cardiac pathophysiology related 
to pressure-overload, where PKG1α oxidation has been implicated38. Under the conditions tested, 
we found no evidence for IDO1 expression and hence role in cardiac tissue after pressure-overload 
(Extended data, fig. 9a). In contrast, IDO1 was expressed in conduit arteries with underlying 
atherosclerosis, as well as in resistance vessels of apolipoprotein E gene knockout (Apoe–/–) but not 
Apoe–/–Ido1–/– mice. More importantly, IDO1 also contributed to the regulation of blood pressure in 
Apoe–/– but not in Apoe–/–Ido1–/– mice (Extended data, fig. 9b-f), indicating that the pathway 
identified here may play a role in blood pressure regulation in atherosclerosis, an inflammatory 
disease. 
In summary, we have demonstrated that 1O2 plays an important pathophysiological role in the 
redox regulation of arterial relaxation and blood pressure in mammals under inflammatory 
conditions where IDO1 is expressed. While mammalian enzymes such as myeloperoxidase have 
long been known to be capable of forming 1O227, a physiological or pathophysiological role for 1O2 
in mammals outside photosensitization reactions has not been established to date. Our findings also 
suggest an expanded range of biological functions for IDO1, and serve as the starting point for 
discovery of a refined repertoire of redox signaling paths by H2O2. For example, the biological 
activities uncovered here highlight the IDO1/PKG1α axis as a possible therapeutic target in sepsis, 
where oxidative activation of PKG1α39 and IDO1 activity are prevalent36. They also raise the 
possibility that the highly reactive and potentially cytotoxic 1O240 may contribute to IDO1-mediated 
immune tolerance and tumor evasion, with inhibition of IDO1 representing a major target of anti-
cancer drug development41,42. Our study shifts focus from H2O2 to an amino acid-derived 
hydroperoxide as a stereospecific signaling molecule. Other heme proteins known to generate 1O2 
in the presence of H2O227 may therefore also play key roles in redox signaling by forming products 
that, like cis-WOOH, act as signaling molecules. 
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Figure 1. Identification of a tryptophan-derived tricyclic hydroperoxide as an arterial 
relaxant. a, Schematic of oxidation of L-tryptophan (Trp) by IDO1 (left) and 1O2 (right). b, 
Relaxation of pre-constricted abdominal aortas from wildtype mice without (naïve) and with 
interferon-γ (IFNγ) pretreatment, and with intact (+EC) or denuded endothelium (-EC), in response 
to purified Kyn (n=9) or N-formylkynurenine (NFK) (n=4). c, Representative myography traces of 
purified Trp-induced relaxation of IFNγ-pretreated abdominal arteries from: wildtype (Ido1+/+) mice 
without (top) and with the IDO1 inhibitor 1-L-methyltryptophan (1-L-MT) (middle); and Ido1–/– 
mice (bottom). d, Relaxation of pre-constricted abdominal aortas from Ido1+/+ or Ido1–/– (n=6) mice 
in response to vehicle (open bars, n=18) or purified Trp (filled bars) ± 1-L-MT (n=5), with IDO1 
expression induced ex vivo by IFNγ-pretreatment or in vivo by lipopolysaccharide (LPS) treatment 
of mice. e, g, Relaxation of pre-constricted endothelium-denuded naïve abdominal aortas to 
increasing amounts of 1O2-exposed Trp containing all compounds present in the crude reaction 
mixture (e, n=4) and HPLC-purified Peak 6 (g, n=6). f, Typical HPLC chromatogram of the crude 
reaction mixture obtained after 1O2 oxidation of Trp for 9 h (n=6), with numbers in bracket 
referring to the molecular mass of the compounds eluting as peaks 2, 4, 5 and 6. h, Chemical 
structure of Peak 6 – cis-WOOH. Data in b, d, e, and g are mean ± s.e.m. *p≤0.05 compared with 
other treatments using Kruskal-Wallis with Dunn’s post hoc test (d) and vehicle (e, g). AU, 
arbitrary units; NE, norepinephrine. 
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Figure 2. Arterial formation of cis-WOOH via oxidative activation of IDO1 dioxygenase 
activity. a, Total LC-MS/MS ion chromatogram of reaction mixtures of recombinant IDO1 and Trp 
under reducing (top, middle) and oxidizing conditions (bottom). b, d, IDO1-mediated formation of 
Trp-derived metabolites with successive (b) or bolus addition of H2O2 (d) in O2- (grey bars) or Ar-
flushed buffer (black bars). Metabolite yield is expressed as percentage of that observed in the 
reaction under air (d). The chemical structure of the peroxidase product, oxyindolylalanine (OIA), 
is shown in (b, right bottom). c, Full mass spectra of cis-WOOH derived from the reaction of IDO1 
and H2O2 with Trp in 16O2 (top, bottom) or 18O2 air (middle), with H2O2 being replaced with H218O2 
(bottom). e, Endogenous formation of H2O2 by porcine arteries in the absence (–) and presence of 
400 ng mL-1 recombinant porcine interferon-γ (rpIFNγ) (+). f, Endogenous formation of 15N2 cis-
WOOH from 15N2 L-Trp by porcine arteries pretreated with 0, 200 or 400 ng mL-1 rpIFNγ. g, Trp-
induced relaxation of mouse abdominal aortas pretreated with mouse recombinant IFNγ and vehicle 
(black, Ctrl), polyethylene glycol (white, PEG) or PEG-catalase (grey, PEG-cat). Data are 
representative of 3 independent experiments (a, c) or mean ± s.e.m. of 3 (b, d, f), 5 (e) and 6 (g) 
independent experiments. *p≤0.05 compared with reaction performed under air (d) or for 
comparisons indicated (e, f, g), using Mann-Whitney rank sum test (d, e) or Kruskal-Wallis with 
Dunn’s post test (f, g). O2•–, superoxide; cis-WOH, hydroxide of cis-WOOH; cytb5, cytochrome b5; 
m/z, mass to charge ratio.  
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Figure 3. Generation of 1O2 by IDO1 and H2O2 is required for formation of cis-WOOH and 
arterial relaxation. a, Fluorescence changes upon addition of H2O2 to Singlet Oxygen Sensor 
Green (SOSG) in the presence of human serum albumin (HSA, red), or IDO1 without (green) and 
with Trp (black). b, LC-MS/MS chromatograms of the reaction mixture of IDO1 and anthracene-
9,10-diyldiethane-2,1-diyl disulfate disodium salt (EAS) after incubation without (top) and with 
H2O2 (bottom). c, Near infrared (NIR) emission upon addition of enzymatically active (black) or 
heat-inactivated (grey) IDO1 to H2O2 before and after Trp addition (left). Difference in NIR 
emission induced under different experimental conditions (right): 1  d, IDO1/H2O2-mediated 
conversion of Trp to cis-WOOH in phosphate buffer containing H2O or D2O with data expressed as 
a ratio of cis-WOOH/oxyindolylalanine (OIA). e, Formation of cis-WOOH by IDO1/H2O2 ± the 
1O2 scavenger L-histidine (L-His), Singlet Oxygen Sensor Green (SOSG), cis-norbixin and urate, 
with data expressed as yield relative to that in the absence of 1O2 scavenger (control). f, Estimation 
of the 1O2 generated by IDO1/H2O2 by quantifying the conversion of EAS to EAS-O2. g, 
Quantification of IDO1/H2O2-mediated conversion of Trp to cis-WOOH, and urate to parabanic 
acid, in the absence (–) and presence of urate (+). h, i Relaxation of mouse abdominal aortas 
pretreated with interferon-γ ± L-His (h), urate (i) or vehicle in response to Trp or sodium 
nitroprusside (SNP). j, Formation of parabanic acid by porcine coronary arteries pretreated with 0 
or 400 ng mL-1 recombinant porcine interferon-γ (rpIFNγ) for 51 h and 8 h in MOPS buffer prior to 
addition of urate. Data are representative of 3 (a), 2 (b) and 3 (c) independent experiments. Data in 
d, e, f, g, h and j are mean ± s.e.m. of 3 independent experiments, while data in i are mean ± s.e.m. 
of n=7 (Trp) and n=4 (SNP) experiments. *#p≤0.05 as determined by Mann-Whitney test for 
comparison with standard reaction condition using 1 µM IDO1 (# in c) or as indicated (* in c, d, g). 
DHPNO2, endoperoxide of N,N-di(2,3-dihydroxypropyl)-1,4-naphthalene dipropanamide, used as a 
positive control; 1, 1 µM IDO1; 2, 2 µM IDO1; N2, reaction mixture bubbled with N2 to remove O2; 
CO and NO, IDO1 treated with CO and NO, respectively; EAS-O2, endoperoxide of EAS.  
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Figure 4. Regulation of arterial relaxation and blood pressure by IDO1-mediated Trp 
metabolism is dependent on cysteine residue 42 of PKG1α . a, Dimerization of recombinant 
human wildtype and cysteine 42 serine (C42S) mutant PKG1α by cis- and trans-WOOH ± light and 
the transition metal chelator diethylenetriaminepentaacetic acid (DTPA); n=3 separate experiments. 
b, c, Dimerization of PKG1α in mouse mesenteric resistance arteries by (b) cis-WOOH (left, naïve 
arteries from wildtype mice, n=10), (right, naïve arteries from Ido1–/– mice, n=4) or (c) Trp (arteries 
from lipopolysaccharide (LPS)-treated wildtype animals, n=4). d, Relaxation of pre-constricted 
mouse mesenteric resistance arteries from wildtype (black) and PKG1α C42S knock-in mice (grey) 
by cis-WOOH (naïve arteries, n=3 for both genotypes), or Trp (n=4 for both genotypes) and the 
nitric oxide donor sodium 2-(N, N-diethylamino)-diazenolate-2-oxide (DEANO) (arteries from 
lipopolysaccharide-treated animals, n=4 for both genotypes). e, f, Blood pressure responses elicited 
by Trp (e), sodium nitroprusside (SNP) (f) in endotoxemic wildtype (black, n=8 for Trp, n=4 for 
SNP) or PKG1α C42S knock-in mice (grey, n=9 for Trp and SNP). g, h, Acetylcholine (ACh)-
induced relaxation of mouse mesenteric resistance arteries from naïve (g) or LPS-treated (h) 
wildtype mice in the absence (control, n=4 for naïve, n=13 for LPS) or presence of Trp (n=4 for 
naïve, n=10 for LPS) or 1-L-methyltryptophan (1-MT, n=4 for naïve, n=8 for LPS). i, Dimerization 
of PKG1α in human smooth muscle cells induced by Trp, 1 µM H2O2 or both, in the presence (+) 
or absence (–) of the IDO1 inhibitor epacadostat (n=5). These cells were pretreated with (+) or 
without (–) 100 ng mL-1 recombinant human interferon-γ (IFNγ) for 72 h. Data are representative or 
mean ± s.e.m. *#p≤0.05 as determined by Mann-Whitney rank sum test (a, b, c), 2-way ANOVA 
with Šidák post-hoc test (d), Kruskal Wallis with Dunn’s test (e, f, i), and 1-way ANOVA of 
maximal relaxation values with Dunnett’s test (g, h).  
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Extended data, figure legends 
Extended data, figure 1. Only Peak 6 induces arterial relaxation in resistance and conduit 
arteries from different vascular beds and species. a, Concentration-dependent arterial relaxation 
of norepinephrine (NE) pre-constricted, endothelium-denuded mouse abdominal aorta by purified 
Peaks 1-6. b-f, Peak 6 concentration-dependent arterial relaxation in endothelium-denuded murine 
(b), rat (c, d, e), and porcine (f) arteries pre-constricted with NE (b, c) or the thromboxane A2 
receptor agonist U46619 (d, e, f). Data show mean ± s.e.m of n=4 (a-e) and n=5 (f) independent 
experiments, with diameter range of the arteries indicated. 
 
Extended data, figure 2. Characterization of reaction products formed during 1O2-mediated 
oxidation of tryptophan by liquid chromatography with tandem mass spectrometry (LC-
MS/MS). a, Representative LC-MS chromatogram of reaction products from the oxidation of L-
tryptophan by Rose Bengal/O2/light showing molecular ions, [M+H]+ for peaks 1-8, representative 
of n=6. b, Tandem mass (MS/MS) spectra of precursor ions with mass-to-charge (m/z) ratio of 221 
(Peaks 2 and 4) and 237 (Peaks 5 and 6), representative of n=2 independent experiments. 
 
Extended data, figure 3. Chemical identification of Peaks 2, 4, 5 and 6. a, HPLC 
chromatograms of reaction products from L-tryptophan oxidation by Rose Bengal/O2/light showing 
retention times of Peaks 1-6 monitored at 230 nm and their corresponding post-column 
chemiluminescence (CL) signals. b, HPLC-UV and CL chromatograms of Peaks 5 and 6 after their 
chemical reduction with sodium borohydride. c, Comparison of molecular ions and fragmentation 
pattern of Peaks 2 and 4 with those of chemically reduced Peaks 5 and 6. d, Comparison of 1H 
NMR spectra of Peaks 2 and 4 (top) with those of chemically reduced Peaks 5 and 6 (bottom). Data 
shown are representative of n=2 independent experiments (a-d). 
 
Extended data, figure 4. Stereochemical characterization of Peaks 2 and 4. a, b, 1H NMR 
spectra (top) of irradiated Peak 2 (a) in CD3OD/D2O and Peak 4 (b) in CD3OD (top spectra). The 
arrow indicates the spectral peak irradiated. The bottom spectra show the respective NOE 
differential spectra of the irradiated peak with the dashed oval indicating anti-phase NOE 
interaction. Data shown are spectra from 1 experiment (a, b). c, d, Structures of Peak 2 (trans-
WOH) and Peak 4 (cis-WOH) showing irradiated proton H8a and indication of the NOE correlation. 
 
Extended data, figure 5. Conversion of cis-WOOH to N-formylkynurenine (NFK). a, Spectral 
changes during incubation of cis-WOOH in phosphate buffer at 37 °C measured in 15 min intervals. 
Arrows indicate increase (↑) and left shift (←) in absorbance, while inset shows spectrum of 
authentic NFK. b, 1H NMR spectra of cis-WOOH in D2O and 25 °C recorded at 5 min (top) and 
360 min (middle). Arrows indicate increases in spectral peaks at 4.1, 7.6, 7.9, 8.1 and 8.3 ppm. 
Bottom shows 1H NMR spectra of authentic NFK. c, Time-dependent loss of cis-WOOH and 
formation of NFK during incubation of cis-WOOH at 37 °C in the presence of 
diethylenetriaminepentaacetic acid, as assessed by LC-MS/MS. d, Light emission upon addition of 
cis-WOOH in D2O phosphate buffer at 72 °C, with corresponding chemiluminescence spectra. e, 
Proposed mechanism of formation of cis-WOOH from 1O2-mediated oxidation of Trp. Data shown 
are representative spectra of 1 (b, c) and 2 separate experiments (a, d). 
 
Extended data, figure 6. Role of 1O2 in IDO1/H2O2-mediated oxidation of Trp to cis-WOOH 
and Trp-induced arterial relaxation. a, LC-MS/MS analysis of cis-WOOH (circles) and trans-
WOOH (squares) following exposure of L-tryptophan to Rose Bengal/O2/light for the time 
indicated. b, Formation of cis- and trans-WOOH during oxidation of Trp by Rose Bengal/O2/light 
(RB) and IDO1/H2O2. c, Inhibition of IDO1/H2O2-mediated cis-WOOH formation by different 
pharmacological IDO1 inhibitors (all tested at 1 mM), with results expressed as the percentage of 
cis-WOOH formed in presence versus absence of inhibitor (control). d, Fluorescence changes upon 
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addition of H2O2 to Singlet Oxygen Sensor Green (SOSG) in the presence of either IDO1 ± 
inactivated carbon monoxide-releasing molecule-A1 (iCORM-A1) (green), IDO1 pre-treated with 
CORM-A1 (red), DEANO (black), or urate (blue). e) Near infrared (NIR) emission upon addition 
of IDO1 pre-treated with CO gas to H2O2. f, Formation of cis- and trans-WOOH during oxidation 
of Trp by horseradish peroxidase (HRP)/H2O2, myeloperoxidase (MPO)/H2O2 and purified 
IDO2/H2O2. g, Trp-induced relaxation of pre-constricted abdominal aortas from wildtype (WT), 
Ido1–/– or Ido1–/–Ido2–/– mice. h, Effect of cis-norbixin (100 µM) on relaxation of mouse mesenteric 
resistance arteries induced by Trp or the nitric oxide donor sodium 2-(N, N-diethylamino)-
diazenolate-2-oxide (DEANO) (arteries from lipopolysaccharide-treated animals, n=4). In b, c, and 
f, reactions were initiated by the addition of H2O2/Trp and the mixtures incubated for 5-15 min at 25 
°C before products were quantified by LC-MS/MS. Data show mean ± s.e.m. or representative data 
(d, e) of 3 independent experiments. 1-MT, 1-methyltryptophan; Ep, epacadostat; NLG, NLG919. 
 
Extended data, figure 7. Mechanism of 1O2 formation by IDO1/H2O2. For all reactions, IDO1 (2 
or 4 µM) was incubated for 5 min (h for 30 min) at 25 °C with 50-fold molar excess of H2O2 in the 
presence of the scavengers and substrates indicated. a, b, Effect of Cu/Zn superoxide dismutase 
(SOD) and N-ethylmaleimide (NEM) on cis-WOOH formation by IDO1/H2O2. Reactions were 
initiated by the addition of H2O2 and the mixtures (containing 100 µM 
diethylenetriaminepentaacetic acid and 100 µM Trp) incubated for 5 min at 25 °C before cis-
WOOH was quantified by LC-MS/MS. Results in a are expressed as the percentage of cis-WOOH 
formed in the presence versus absence (control) of 100 U SOD, whereas in b results are expressed 
as percentage of Trp converted to cis-WOOH. c, Effect of IDO1/H2O2 on conversion of 
hydroethidine (HE) to 2-chloroethidium (2-Cl-E+) in phosphate buffered saline (PBS), as 
determined by LC-MS/MS. d, Effect of scavengers of excited carbonyls (sorbate) and oxygen-
centered radicals (5,5-dimethyl-1-pyrroline N-oxide; DMPO) on the formation of cis-WOOH by 
IDO1/H2O2. e, Formation of IDO1 fragments (double arrow) and dimers (arrow) upon reaction of 
IDO1 with H2O2 in the absence or presence of Trp or DMPO as assessed by SDS-PAGE under non-
reducing conditions and visualization of proteins by silver stain. f, g, Formation of dityrosine and 
IDO1 hydroperoxides during exposure of IDO1 to H2O2 in 100 mM phosphate buffer in the absence 
of Trp ± DMPO (f) or ± ascorbate (Asc, g). Reaction mixtures were subjected to size exclusion 
chromatography with HPLC-UV214nm (left) and (f) fluorescence or (g) post-column 
chemiluminescence (CL) detection (right). Ascorbate was used as a reductant for protein 
hydroperoxides. h, IDO1/H2O2-mediated conversion of EAS (1 mM) to EAS endoperoxide (EAS-
O2) in the absence and presence of DMPO. i, Formation of protein carbonyls during reaction of 
IDO1 with H2O2 in the absence and presence of DMPO. Following reaction, IDO1 was denatured 
with 6% SDS in the presence of dinitrophenylhydrazine (DNPH) before protein was transferred 
onto nitrocellulose membrane, and carbonyls detected using anti- DNPH antibody. Qualitative data 
are representative of 2-3 separate experiments. Quantitative data show mean ± s.e.m. of 3 
independent experiments. *P≤0.05 (Mann-Whitney test). 
 
Extended data, figure 8. Role of protein kinase G1α  (PKG1α) in arterial relaxation by 
IDO1/cis-WOOH. a, b Concentration-response curves to cis-WOOH after pre-treatment of 
denuded mouse abdominal aortas with vehicle (filled squares) or the competitive cGMP PKG 
inhibitor RP-8CPT-cGMP (a, open squares), or the competitive ATP binding PKG inhibitor 
KT5283 (b, open squares). c, d, IDO activity in kidney homogenate (c) or plasma (d) obtained from 
wildtype (WT) or PKG1α C42S knock-in (KI) mice after treatment with lipopolysaccharide. Data 
show mean ± s.e.m. of 5 (a), 4 (b, c) or 6 (d) independent experiments. *p≤0.05 using repeated 
measures 2-way ANOVA with Šidák multiple comparison post-hoc test. NS, not significant (Mann-
Whitney test). 
 
Extended data, figure 9. Role of IDO1 in pressure-overload related cardiac pathophysiology 
and experimental atherosclerosis. a, Cardiac expression of Ido1 mRNA after sham and transverse 
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aortic constriction (TAC) for 21 days, with IFNγ-treated hearts as positive control. Inset: increase in 
ventricle weight-to-tibia length ratio as evidence for TAC-induced cardiac hypertrophy. b, c, IDO1 
staining (brown color) in (b) atherosclerotic lesions of thoracic aorta and (c) resistance vessel of 
kidney of Apoe–/– (top) and Apoe–/–Ido1–/– (middle) mice after six months of Western Diet (WD), 
with isotype rabbit IgG as control (bottom). Magnification 60x (b) and 20x (c). Arrow heads (c) 
indicate microvessels. d, Plasma concentrations of L-tryptophan (Trp) and kynurenine (Kyn) in 
Apoe–/– and Apoe–/–Ido1–/– mice after six months of WD. e, Trp-induced relaxation of pre-
constricted, atherosclerotic lesion-containing aortic rings isolated from Apoe–/– and Apoe–/–Ido1–/– 
mice in the presence or absence of IDO1 inhibitor 1-methyltryptophan (1-MT) after six months of 
WD. f, Systolic blood pressure (SBP) of Apoe–/– and Apoe–/–Ido1–/– mice before (−) and after (+) 
administration of 1-D-MT. n, number of mice used. *p≤0.05 (Mann-Whitney test). 
 
Extended data, table 1. 1H and 13C NMR data for purified Peaks 2, 4, 5 and 6 in D2O 
(calibrated to 4.79 ppm) 
 
Extended data, scheme 1. Proposed mechanism for formation of 1O2 by IDO1 plus H2O2. 
Reaction of Fe3+-heme IDO1 with H2O2 results in formation of the two-electron oxidized form, 
compound I, consisting of a Fe4+=O iron center and a porphyrin cation radical (not shown). The 
latter is transferred to an amino acid side chain of IDO1, such as Trp (not shown) or, more likely, 
Tyr such as Y126 or Y353 that are close to the active site heme in IDO143. The IDO1 tyrosyl 
radical may then engage in the formation of fluorescent di-tyrosine crosslinks or H-abstraction 
reactions leading to protein fragmentation according to established pathways30. Alternatively, a 
resonance form of the IDO1 tyrosyl radical may add to molecular oxygen. The resulting 
intermediate quinone peroxyl radical may then participate in inter- or intra-residue peroxyl radical 
combination, the latter subsequent to additional H-abstraction and oxidation reactions and 
formation of a putative intra-residue di-peroxyl radical. The resulting tetroxides will decay with 
release of 1O2 according to the Russell Mechanism32. The observed stereospecific formation of cis-
WOOH by IDO1/H2O2/L-Trp suggests formation of 1O2 close to the active site heme rather than 
release into the bulk phase, and may therefore be more consistent with the intra-residue peroxyl 
radical combination pathway. 
 
Extended data, scheme 2. Chemical synthesis of epacadostat. 
